| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Immunome Inc. | IMNM | Grant | Common Stock | 60.8k | $0.00 | $0 | | 10/02/2023 |
| 10/02/2023 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 137.7k | $1.35 | $185.9k | | 10/02/2023 |
| 06/08/2023 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 6.5k | $4.84 | $31.5k | | 06/08/2023 |
| 09/09/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 37.6k | $0.60 | $22.6k | | 09/09/2022 |
| 06/16/2022 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 6.5k | $2.62 | $17k | | 06/16/2022 |
| 11/04/2021 | Lantern Pharma Inc. | LTRN | Grant | Stock Option (Right to Buy) | 3.2k | $10.32 | $33k | | 11/04/2021 |
| 08/19/2021 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 38.1k | $3.36 | $128.1k | | 08/19/2021 |
| 06/16/2021 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 7.5k | $16.96 | $127.2k | | 06/16/2021 |
| 09/09/2020 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 14.6k | $8.80 | $128.8k | | 09/09/2020 |
| 06/15/2020 | Lantern Pharma Inc. | LTRN | Grant | Stock Option | 9.1k | $0.00 | $0 | | 06/15/2020 |
| 07/23/2019 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 100k | $0.15 | $15k | | 07/23/2019 |
| 07/12/2019 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 227.3k | $5.39 | $1.2M | | 07/12/2019 |
| 11/20/2017 | ELI LILLY & Co | LLY | Grant | Common Stock | 802 | $83.18 | $66.7k | | 11/20/2017 |
| 09/28/2017 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 2.5k | $0.00 | $0 | | 09/28/2017 |
| 09/28/2017 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 5k | $2.75 | $13.8k | | 09/28/2017 |
| 06/07/2017 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 2.5k | $0.00 | $0 | | 06/07/2017 |
| 06/07/2017 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $4.15 | $41.5k | | 06/07/2017 |
| 10/11/2016 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 2.5k | $0.00 | $0 | | 10/11/2016 |
| 10/11/2016 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $1.81 | $18.1k | | 10/11/2016 |
| 11/30/2015 | ELI LILLY & Co | LLY | Grant | Common Stock | 1.8k | $81.23 | $145k | | 11/30/2015 |
| 05/14/2015 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $10.74 | $107.4k | | 05/14/2015 |
| 11/28/2014 | ELI LILLY & Co | LLY | Grant | Common Stock | 2.2k | $67.29 | $145k | | 11/28/2014 |
| 05/22/2014 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 5k | $0.00 | $0 | | 05/22/2014 |
| 05/22/2014 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $11.70 | $117k | | 05/22/2014 |
| 10/10/2013 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $15.39 | $153.9k | | 10/10/2013 |